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Abstract: Deoxynivalenol (DON), a trichothecene mycotoxin produced by Fusarium species, is the
most widespread mycotoxin in poultry feed worldwide. Long term-exposure from low to moderate
DON concentrations can produce alteration in growth performance and impairment of the health
status of birds. To evaluate the efficacy of mycotoxin-detoxifying agent alleviating the toxic effects of
DON, the most relevant biomarkers of toxicity of DON in chickens should be firstly determined. The
specific biomarker of exposure of DON in chickens is DON-3 sulphate found in different biological
matrices (plasma and excreta). Regarding the nonspecific biomarkers called also biomarkers of effect,
the most relevant ones are the impairment of the productive parameters, the intestinal morphology
(reduction of villus height) and the enlargement of the gizzard. Moreover, the biomarkers of effect
related to physiology (decrease of blood proteins, triglycerides, hemoglobin, erythrocytes, and
lymphocytes and the increase of alanine transaminase (ALT)), immunity (response to common
vaccines and release of some proinflammatory cytokines) and welfare status of the birds (such as the
increase of Thiobarbituric acid reactive substances (TBARS) and the stress index), has been reported.
This review highlights the available information regarding both types of biomarkers of DON toxicity
in chickens.
Keywords: deoxynivalenol; chickens; deoxynivalenol-3 sulphate; biomarkers
Key Contribution: This is a review reporting the specific and unspecific biomarkers of toxicity of
deoxynivalenol mycotoxin in chickens.
1. Introduction
The consumption of poultry meat has shown an increase from 2016 (116,845.36 thou-
sand metric ton) to 2018 (120,884.63 thousand metric ton) [1]. Moreover, during the period
2020–2029, global livestock production is expected to expand by 14%, poultry remaining
the fastest growing meat accounting for about half of the projected increase in total meat
output, while world population is expected to grow only by ca 1% per year [1].
The goal of the poultry industry is to ensure high productivity without jeopardizing
product quality and safety. For this reason, ensuring microbiological and toxicological
safety of poultry feed entails a major challenge.
Mycotoxins are fungal metabolites frequently found in feeds that can compromise
the health of animals and humans [2]. Besides, mycotoxin feed contamination leads to
important economic losses in animal production [3]. Mycotoxins can cause a large range of
diseases, as well as death, to both humans and animals [4]. The most important mycotoxins
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associated with poultry health and productivity problems are aflatoxins (AF), fumonisins
(FBs), ochratoxin A (OTA), zearalenone (ZEN) and trichothecenes such as deoxynivalenol
(DON), and T-2 toxin [5].
As DON is the most frequently encountered mycotoxin in cereal commodities [6], it is
not surprising that DON is a major contaminant of poultry feed. A recent large scale survey
monitored the occurrence of mycotoxin from 2008 to 2017 in 74,821 samples of finished feed,
maize, maize dried distillers grains with soluble (DDGS), maize silage, soybean grains,
soybean meal, wheat, barley, and rice collected from 100 countries for the presence of AFB1,
DON, ZEN, FBs, OTA, and T-2 [7]. DON was the most prevalent Fusarium mycotoxin
followed by FBs and ZEN, mycotoxins were detected in 64%, 60%, and 45% of all samples,
respectively [7].
DON is produced predominantly by Fusarium graminearum and Fusarium culmorum
and, at to a lesser extent, by Fusarium cerealis and Fusarium pseudograminearum, under
conditions of high moisture and low temperature [8]. DON mainly occurs when grains are
still in the field, although it can also occur during improper storage [9]. As all trichothecenes,
DON contains a tetracyclic sesquiterpenoid 12,13-epoxytrichothecene core, responsible
for their cytotoxicity, and a 9, 10 double bonds with various side chain substitutions [10].
Structurally, DON is a polar compound composed of three free hydroxyl groups (-OH)
which participate also in its toxicity [11]. DON is a thermostable compound and also is
able to resist low pH levels [12]. DON has been classified by the International Agency for
Research on Cancer (IARC) in group 3 as noncarcinogenic to humans [13]. At cellular level,
DON is a protein synthesis inhibitor, which induces ribotoxic and oxidative stress [14–16].
Acute DON mycotoxicosis in broiler chickens is rare to occur due to the extremely high
feed contamination [8]. Only one study reported the Acute DON mycotoxicosis in broiler
chickens which is characterized by extensive ecchymotic hemorrhages, deposition of urates,
alteration of the nervous system, and inflammation of the upper gastrointestinal tract [17].
However, the most common mycotoxicosis is due to chronic exposure from low to moderate
level of DON and resulted in alteration of the production and health status of the birds
which is manifested in alterations of performance, immune, intestinal, physiological, and
welfare parameters [18–20].
Susceptibility to DON exposure depends on the affected species [21]. Poultry, for
example, are considered resistant to DON mycotoxicosis in comparison with pigs, due to
differences on the absorption, distribution, metabolism, and excretion (ADME) process of
each species [22]. The guidance level of EU in poultry feed is about 5 mg/kg while for pigs
is only 0.9 mg/kg [23].
The presence of mycotoxins in food and feed is practically unavoidable due to their
stability. Moreover, the simultaneous presence of different mycotoxins in the recent survey
is the rule rather than the exception [7]. The simultaneous presence of DON and ZEN, or
DON and FBs were the most observed (48%) in the case of finished feed. It happens in a
similar way with corn, with co-occurrences of DON and ZEN in 39%, and DON and FBs in
49% of the samples. The most frequent combination in wheat was DON and ZEN, which
was detected in 28% in the samples [7].
Therefore, in order to minimize the risks posed by mycotoxins, the use of feed ad-
ditives known as mycotoxins detoxifiers seems to be a good strategy to counteract the
negative effects induced by mycotoxin, and this is the most common practice used to-
day [24]. In 2019, the feed mycotoxin detoxifiers market was valued at USD 1204.0 million
and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.4% during the
forecast period (2020–2025) [1]. North America and Asia Pacific are the greatest zone using
detoxifiers. The market in Asia Pacific is projected to be the fastest-growing, due to large
livestock population and their increasing growth rate [25].
The efficacy and safety of these feed additives has been proven through the evaluation
of biological biomarkers related to mycotoxin toxicity in a target species [26]. The use of
biological biomarkers is highly reliable because they provide a basis for the designing of the
in vitro and in vivo trials [26]. In this context, research has been conducted to demonstrate
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the efficacy of detoxifying-agents on unspecific biomarkers such as zootechnical parameters,
organ weights, and physiological, immunological, and welfare indicators [27]. However, in
the scientific opinion focusing on the experimental design of in vivo studies on the efficacy
and safety testing of mycotoxin-detoxifying agents, the European Food Safety Authority
(EFSA) has listed several relevant end-points for the different mycotoxins [28]. These
end-points, also named biomarkers of exposure, are those directly related to mycotoxin
toxicity. For DON, the most relevant end-points proposed are DON itself and its metabolite
deepoxy-deoxynivalenol (DOM-1) in blood [28].
This review highlights the biomarkers of exposure and biomarkers of effect of DON in
chickens, with special emphasis on metabolic and welfare parameters, in order to identify
its impact and therefore facilitate the evaluation of the efficacy of detoxifying-agents. This
review may also represent a useful tool for diagnosis of birds in the field.
2. Biomarkers of Exposure
Specific well-characterized biomarkers have shown to predict relevant clinical out-
comes across a variety of treatments and populations [26]. Up to date, the use of biomarkers
has become commonplace, and biomarker-driven research has been proposed as a success-
ful method [29]. The biomarkers of exposure are defined as the metabolites estimated in
biological fluids upon the exposure to xenobiotics of individuals [29]. The biomarkers of
exposure must be specific for each mycotoxin and target species, and the analytical method
used for its detection must be validated for each biological matrix considered [28]. As
previously mentioned, EFSA has indicated that the relevant biomarkers directly related
to exposure of DON are DON and DOM-1, revealing that de-epoxidation is the most
important pathway of metabolization of DON [28]. However, research conducted in differ-
ent species revealed that the metabolization pathway of DON is species-dependent, and
de-epoxidation has shown not to be an important pathway of metabolization for poultry
species [30].
The metabolization of DON may be changed if the birds are exposed to DON in a
chronic feeding design or to intravenous injection or oral bolus of the synthetic or labeled
DON, also by the biological matrices and the sensitivity of the method of analysis used. The
most relevant biomarkers of DON exposure in chickens and their methods of determination
are reported in Table 1.
After chronic feeding of DON at 7.54 or 9.5 mg/kg to broiler chickens, DON was
quantified as the main metabolite in plasma using LC–MS/MS with limit of quantification
(LOQ) (0.1 to 1.25 ng/mL) [32,34]. However, the concentration of DON in plasma was
under the LOQ (1.25 or 23.3 ng/mL) when broilers were fed lower (1 or 2.44 mg DON/kg
feed) or equal to the guidance level of DON in poultry feed (5 mg/kg feed) [31,33,34].
On the other hand, DON was the only metabolite detected in the plasma when broilers
were exposed to the equivalent to guidance level (approximately 0.5–0.75 mg/kg BW)
intravenously or by oral gavage in a two-way cross-over design, using LC-MS/MS with
LOQ (0.1–2.5 ng/mL) [22,38,39]. Furthermore, after 2 h post-administration no DON levels
in broilers plasma above LOQ were detected [38]. The study of toxicokinetic parameters
upon quantification of DON in plasma revealed a low absolute oral bioavailability (19.3%)
or absorbed fraction (10.6%) due to the poor absorption of DON [22,38,39]. This low
absorption may be partially related to the rapid transit time in the gastrointestinal tract
of birds. The authors suggested also that this poor bioavailability could be associated to
the metabolization of DON by the high bacterial content in the gastrointestinal tract of
chickens before the main site of absorption [22]. Additionally, it has been reported that the
high clearance with the rapid elimination half-life might be the reasons why poultry are
relatively tolerant to DON mycotoxicosis [38].
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Table 1. Biomarkers of exposure of deoxynivalenol (DON) in chickens.
DON 1 Dose Route Matrix Metabolites 2 Analyzed Analysis 3 Method LOQ (ng/mL or ng/g) 4 Main Metabolite Reference
Acute or chronic administration of DON (farm studies)






13.2 (bile, liver, and breast meat) - [31]





1 or 5 mg/kg Feed




DOM-1 HPLC-MS/MS 23.3 DON [33]
2.44 or 7.54 mg/kg Feed Plasma, liver, kidney, bile DONDOM-1 LC–MS/MS 1.25
DON (plasma and bile)
DOM-1 (bile) [34]









1.7 mg/kg Feed Excreta
DON-3S
DOM-3S
DON, DOM, DON sulfonates
1,2,3, and DOM sulfonate 2
LC–HR-MS/MS
1 for DON sulfonates 1,2,3,





0.5 mg/kg BW Single intra-crop bolus Plasma and excreta DONDON-3S LC–MS/MS and HR-MS 1 DON-3S [37]
Toxicokinetics studies (laboratory studies)
0.75 mg/kg BW Intravenous injection ororal gavage Plasma
DON
DOM-1 LC–MS/MS 1–2.5 DON [38]





LC–MS/MS 0.1-2 DON [22,39]







LC–MS/MS 0.1 DON-3S [30]
0.77 DON-3G mg/kg BW






LC–MS/MS and HR-MS 1 DON-3S [40]
1 DON, deoxynivalenol; 2 DOM-1, deepoxy-deoxynivalenol; ADON, acetyl-deoxynivalenol; DON-3S, deoxynivalenol-3-sulphate; DON-3G, deoxynivalenol-3-glucuronide; 3 HPLC, high performance liquid
chromatography; LC–ESI-MS/MS, liquid chromatography–electro-spray ionization tandem mass spectrometry; LC–MS/MS, liquid chromatography–mass spectrometry; radio-HPLC-IT-TOF-MS/MS; radiotracer
method coupled with a novel γ-accurate radioisotope counting (γ-ARC) radio-high-performance liquid chromatography ion trap time-of-flight tandem mass spectrometry system; 4 ng/mL (fluids) or ng/g
(organs and excreta); 5 gastrointestinal tract, plasma, bile, brain, heart, liver, kidney, lung, spleen, pancreas, urinary bladder, ovary/testis, adipose, muscle, and skin.
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Awad et al. [33] indicated that after exposure of DON in feed (1 or 5 mg/kg) to
broiler chickens for 35 days, DON concentration was recovered around 10–12% in gizzard,
18–22% in cecum and only 6% in excreta of the DON administered. DON was not detected
in liver and bile. Moreover, the DON concentration in the content (digesta) of gizzard,
cecum, rectum, and excreta increased in a dose dependent manner. In contrast, DON
could not be quantified in bile, liver, breast meat, and kidney [31,34]. The analysis of DON
and its metabolites using HPLC in broiler chickens receiving an oral administration of
tritium-labelled DON at the dose of 2.5 mg/kg BW for 5 days, indicated that DON was
transiently distributed and rapidly eliminated in all tissues [35]. Low DON concentrations
were detected in kidney, liver, heart, lung, spleen, and brain and the higher level was
detected in small intestine 6 h post-administration.
With regard to DOM-1, several studies analyzed this metabolite in plasma, in different
organs, or in excreta after chronic DON feeding, intravenous injection or oral gavage
using LC–MS/MS [22,30–34,36,38–40]. However, only in very few studies DOM-1 could
be quantified [32,34].
All studies mentioned followed the guidelines proposed by EFSA and quantified DON
and DOM-1 as possible metabolites of exposure of DON in different biological matrices
of chickens, but they found inconsistent results. The inconsistent results may be partially
explained by different levels of 3 and 15 acetyl-DON in the feed. The lack of detection of
DOM-1 could be explained by the fact that sulfation occurred so quickly that only DON-3S
can be transformed to DOM-3S.
The high-resolution mass spectrometry (HRMS) is a very recent analytical method
used to identify or detect the untargeted or novel metabolites, biotransformation products
and/or modified fungal metabolites [41]. Since 2014, and with the improvement of the
analytical methods it was reported that the most abundant metabolite in case of broiler
chickens after receiving DON mycotoxin was a phase II metabolite named DON-3 sulphate
(DON-3S) [35]. Still, the formation of DON-3S was observed also in turkeys, pigeons
and laying hens [30,37,42,43]. Furthermore, in poultry no DON glucuronidation has been
observed [30].
DON-3S was identified the first time as a new and major metabolite in poultry in the
study of Wan et al. [35]. Among the three new metabolites identified (DON-3S, 10-DON-
sulfonate, and 10-DOM-1-sulfonate), DON-3S was the major metabolite found in excreta
of chickens (88.6%) after the oral administration of tritium-labeled DON at the dose of
2.5 mg/kg BW for 5 days. [35].
Subsequently, Devreese et al. [30], using HRMS analysis of plasma of turkeys and
broiler chickens, found that DON-3S was the major metabolite after oral gavage as well as
after intravenous injection of 0.75 mg DON/kg BW [30]. Broiler chickens biotransform or
metabolize DON more extensively to DON-3S than turkeys [30]. The authors suggested
that sulfation mainly occurred in the enterocytes of the intestinal mucosa [36]. Similarly,
the analysis by LC–HRMS indicated that DON-3S was mainly present in plasma of broiler
chickens dosed at 0.5 mg DON/kg BW after intravenous or oral DON administration,
respectively; and that DON-3G was not hydrolyzed to DON in this species [40]. The
authors concluded that chickens are less sensitive to DON toxicity and explained this
relative tolerance by the rapid gastrointestinal transit time or by the extensive and rapid
sulfation that occurred.
Schwartz-Zimmermann et al. [36] demonstrated that DON-3S was the best biomarker
of exposure in all poultry species. In chickens, for example, biological recovery of DON-3S
in excreta reached 80% after administration of DON (1.7 mg/kg feed). These authors
indicated that DON is rapidly absorbed from the gastrointestinal tract between crop and
jejunum. Then, they suggested that after absorption, DON is extensively biotransformed to
DON-3S in the intestinal mucosa, liver and/or kidney. The elimination of DON-3S is rapid
and complete into the cloaca via urine by the kidney (via the renal portal vein system in
birds), or might be in part be subject to biliary excretion and excreted via feces, or back into
the gastrointestinal tract via bile by the liver [36,43].
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It was demonstrated also that the most suitable biomarker for exposure of DON in
poultry is DON-3S detected in different biological matrices (plasma and excreta); after a
single intra-crop bolus administration of 0.5 mg DON/kg BW to broiler chickens aged
21 days and weighed 1 kg, DON-3S was detected and DON was not found. The maximum
peak area of DON-3S was achieved in plasma after 30 min post administration and after
3–6 h in dried excreta [37].
In conclusion, DON and DOM-1 are not considered ideal biomarkers in the different
biological matrices of chickens. Interestingly, the most abundant metabolite in plasma and
excreta of chickens is DON-3S which could be considered the most suitable biomarker
of exposure of DON in chickens. This metabolization is a detoxification pathway [44].
On the other hand, the toxicokinetic behavior of DON in chickens was characterized by
low absorption, rapid gastrointestinal transit time, transient distribution, high clearance,
and rapid elimination. All these factors may explain the low susceptibility of broilers to
DON toxicity.
3. Biomarkers of Effect
A biomarker of effect is evaluated through a biochemical, physiological, immuno-
logical, behavioral, or other organism’s alteration [29]. Depending upon the magnitude,
the biomarker of effect can be recognized as associated with an established or possible
health impairment or disease [29]. Biomarkers of effect are biomarkers indirectly related
to mycotoxin toxicity. The biomarkers of effect of DON toxicity in chickens highlighted
in this review are productive parameters, organ weights, morphology of small intestine,
biochemical and hematological parameters, biomarkers related to immune system (com-
mon vaccines response as a part of humoral immune response, cellular immune response,
and production of proinflammatory cytokines), and biomarkers related to chicken welfare.
To our knowledge, this is the first time that the indicators of toxicity in chickens related to
welfare are grouped in a review.
3.1. Productive Parameters
Studies about the effects of DON on productive parameters in chickens are listed in
Table 2.
The chronic ingestion of DON can cause decrease of feed consumption, body weight
gain (BWG) and feed efficiency in chickens [62]. Even at lower concentrations than the
recommended guidance value (5 mg DON/kg feed), the presence of DON in chickens
feed might have growth inhibitory effects [54,55,61]. A decreased BWG of broilers fed
1.68 mg DON/kg feed at 21 days has been observed [61]. Slow growing chicks fed 2 mg
DON/kg feed had lower BWG [54]. The body weight (BW) and feed intake of broiler
chickens have shown to be reduced after feeding 2.5 mg DON/kg feed for 35 days [55].
Furthermore, DON exposure from 5 to 14 mg/kg of feed for 35 days had adverse effects on
BW, BWG, feed intake, and feed conversion ratio of chickens [27,55,56,62]. Broiler chickens
exposed to DON from 15 to 18 mg/kg feed for 21 days also showed lower performance
compared with controls, according to several studies [63–65,69]. Recently, Riahi et al. [19]
also reported that the use of DON artificially contaminated feed (15 mg/kg) during 42 days
reduced the BWG and altered the feed conversion ratio. The poor performance occurring
in the presence of DON in feed could be related to the mode of action of this toxin, that is
principally the inhibition of protein synthesis at the elongation or termination steps [14].
It was shown also that DON adverse effects on chicken’s productive parameters may
appear only during specific parts of their growth cycle [51].
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Table 2. Effects of deoxynivalenol (DON) on productive parameters of chickens.
Breed DON 1 (mg/kg) Diet Source of Contamination Exposure Duration (day) Reported Effects 2 Percentage of Variation % Reference
Lohmann Meat 1.5 Artificial 35 ↑ BWG↓ feed conversion ratio
8
10 [31]
Shaver up to 1.87 Artificial 28 None - [45]
Ross 308 4.6 Artificial 15 None - [46]
Leghorn chicks (Ottawa strain 10) 4.6 Natural 28 (from day 7 to 35) ↑ BWG↑ feed intake
2
4 [47]
Ross 308 1 or 5 Natural 35
↓ feed intake (7 days) (1 mg/kg)
↓ BW (14 days)





Cobb × Cobb 500 1.5 or 5 Artificial 21 None - [48]
Ross E032 5 Natural 21 ↓ feed intake (14–21 days) 20 [49]
Ross 308 5 Artificial 28 None - [50]











Ross × Ross, Maple Leaf Poultry 4.7 or 8.2 Natural 56
↑ feed intake
↑ BWG
At 4.7 (42 to 56 days)
4
2 [52]
Ross × Ross, Maple Leaf Poultry 5.9 or 9.5 Natural 56
↓ BWG
↓ feed consumption
(day 21 to 42)
9 or 12
8 or 14 [53]
Black-feathered Taiwan country chickens 2, 5 or 10 Artificial 112 BWG at 2 mg/kg lower than BWG at 5 mg/kg 8 [54]
Ross 308 2.5, 5 or 10 Artificial 35
Overall the trial: ↓ BW at 2.5 and 5 mg/kg,
↓ BWG at 5 mg/kg
↓ feed intake at all doses.
At week 5: ↓ BW at 5 mg/kg







Ross 308 5 or 10 - 35
↓ BW
↓ BWG (28 days)
↓ feed intake (28 days)
















Ross 308 10 Artificial 35 None - [57]
Ross 308 10 Artificial 35 None - [58]
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Table 2. Cont.
Breed DON 1 (mg/kg) Diet Source of Contamination Exposure Duration (day) Reported Effects 2 Percentage of Variation % Reference
Ross E032 10 Artificial 42 None - [59]
Ross E032 10 Artificial 42 None - [60]
Ross 308 1.68 or 12.20 Artificial 35 ↓ feed intake↓ BWG (21 days)
8 or 13
12 or 17 [61]
Lohmann broilers Up to 14 Natural 35
↓ feed intake
↓BW





Ross 308 5 or 15 Artificial 42 ↓ BWG↑ in feed conversion ratio at 15 mg/kg
6
7 [19]
- 15 Natural 21 ↓ BWG↑ in feed conversion ratio
19
28 [63]
Hubbard × Hubbard 16 Natural 21 ↓BWG↑ feed conversion
10
23 [64]
Hubbard × Hubbard 16 Natural 21 ↓BWG↑ feed conversion
9
20 [65]
Hubbard × Hubbard 16 Natural 21
↓BW
↑ feed conversion (day 8 to 14) 224 [66]
- 16 Natural 21 None - [67]
Leghorn chicks 9 or 18 Natural 35 ↑ BW (at 18 mg/kg day 21)↑ BW (at 9 mg/kg day 35)
7
8 [68]
Ross 708 Up to 18 Natural 21 ↓ feed intake↓ BWG
8
10 [69]
Leghorn chicks 18 Natural 84 ↑ BW at 28 and 56 days 5 and 8 [70]
White Mountain 6"
× Hubbard 9 Up to 216 Natural From 6 to 11 None - [71]
1 DON, deoxynivalenol; 2 BW, body weight; BWG, body weight gain; ↑, increase; ↓, decrease.
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Awad et al. [28] noted that the adverse effect of DON was only pronounced at the
beginning of the experiment, but no effect was observed later on BW, BWG, feed consump-
tion, and feed conversion ratio. In fact, they found that feeding DON at 1 or 5 mg/kg to
broiler chickens decreased the feed intake in a quadratic manner during the first week
and BW and BWG during the second week [33]. Moreover, a reduction of feed intake was
observed only at the third week of the trial after DON (5 mg/kg) exposure to broilers [49].
Adverse DON temporary effect on growth performance was also observed in chickens fed
1.68 or 12.20 mg DON/kg feed during the 21 days of exposure, and this effect disappear
later [61]. BWG was only reduced during the second week in the study conducted by
Kubena et al. [66], which used 16 mg DON/kg of feed during 21 days. The meta-analysis
conducted by Andretta et al. [72] reported that the effect of mycotoxins on broiler’s growth
was greater in young broilers.
It has been hypothesized that the temporal effect produced especially at the early stages
of chicken development is related to the capacity of birds to later adapt to DON mycotoxicosis.
In contrast, few studies found that broilers are more sensitive to DON-contaminated
diets during later stage of growth. Feeding DON from 5.9 to 9.5 mg/kg feed to broilers
reduced BWG and feed intake during the grower period (21 to 42 days) [53]. Broiler
chickens fed 7.90 mg DON/kg feed from 21 to 34 days had lower BW, BWG, feed intake,
and altered feed conversion ratio [51]. The authors concluded from this study that after
chronic exposure to DON-contaminated diets, the adverse effects on growth performance
are not necessarily cumulative [51].
However, other reports indicated that DON at low, moderate, high or extremely
high levels had no adverse effects on poultry performance. The exposure to naturally
contaminated DON diets, containing 1.5–1.87 mg DON/kg to broiler chickens for 21 or
28 days had no effects on BW, BWG, feed consumption, and feed conversion [45,48]. The
absence of effect could be due to a level of DON contamination sharply lower than ones
adopted in the previous research [51,53]. No adverse effect was indicated on broiler
performance feeding the guidance value for 15, 21, 28, or 42 d, respectively [19,46,48,50].
BW, BWG, feed intake, and feed conversion ratio were not adversely affected by the
inclusion of 10 mg DON/kg in broiler diets for 35 or 42 days [57–60]. Productive parameters
of birds exposed to 16 mg DON/kg feed for 21 days were not adversely affected [67]. Even
high level of an artificially DON contaminated diet (116 mg/kg) did not adversely affect
BWG and feed consumption of broiler chickens from 6 to 11 days [71]. Failure to observe
significant differences on growth parameters might be suggestive of adaptation of birds
to mycotoxins over time, and that poultry are relatively tolerant to DON mycotoxicosis
compared with other species, especially pigs, due to the differences in DON absorption,
distribution, metabolism, and elimination (ADME) [22].
Furthermore, it has been reported that DON could have growth stimulatory effects.
Some studies indicate that DON in poultry feed enhance growth. Feeding 4.6 mg DON/kg
feed to Leghorn and broiler chicks for 4 weeks (between 7 and 35 days of age) increased
their daily BWG [47]. In the same manner, BW of male Leghorn chicks was increased when
fed 9 mg DON/kg feed at 35 days and 18 mg DON/kg feed at 21, 28 and 56 days [68,70].
In addition, the inclusion levels of 4.7 or 8.2 mg DON/kg in broiler chickens feed
increased BWG and feed intake in a significant quadratic manner in the finisher period [52].
A contaminated diet with DON at 1.5 mg/kg for 35 days enhanced broiler performance by
increasing the BWG and reducing the feed conversion ratio [31]. The enhancement of per-
formance might be the consequence of the increase of nutriments digestibility induced by
the presence of the fungus in the grains [62]. Taiwan country chickens exposed to 5 mg/kg
of DON in feed during 16 weeks showed a growth promoting impact in comparison with
chickens receiving 2 mg DON/kg [54]. It has been suggested that this concentration near
to or equal to 5 mg/kg could have a stimulator and promoting effect on growth of broilers
and it was described as an hormesis phenomenon [52], resulting in either a J-shaped or an
inverted U-shaped dose response.
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In summary, the adverse effect of DON on broiler performance is the most frequent
effect reported among studies. The impairment of BWG, feed intake, and feed conversion
ratio could reach up 37, 25 and 35%, respectively [27].
The improvement of genetics of broiler chickens over the years could be a factor of
consideration of growth effects. In fact, rapidly growing birds may have altered metabolic
and nutrient partitioning and has long-been criticized in reducing immunity [73]. Then,
rapidly growing birds are more susceptible to detrimental effects of mycotoxins on growth.
The effects of DON on productive parameters may depend on the dose and the duration
of exposure. The source of mycotoxin used (naturally vs. artificially) is considered also
a factor of variation of DON toxicity, in which natural contaminated diets with DON are
more frequently toxic than artificially contaminated diets, as reported in Table 2. Moreover,
in natural contamination, multi-mycotoxin contamination is very frequent, as most of fungi
are able to produce several mycotoxins simultaneously, and feed can be contaminated
by several fungi species at the same time. Thus, mycotoxin multicontamination of raw
materials is more likely to occur than a single mycotoxin contamination [10,74]. Addition-
ally, the presence of acetylated and glycosylated forms of DON in naturally contaminated
feed can increase the global toxicity as these forms are cleaved into DON in digestive tract
of animals [75]. In addition, the effects of DON on productive parameters may depend
on the climatic factors, the methods of analysis of mycotoxins and the adaptability and
the tolerance of chickens to DON mycotoxicosis [5,48]. This tolerance may be due to the
biotransformation of DON to DON-3S in chickens, which is much less toxic than DON
itself [35].
3.2. Relative Weight of Organs
The effect of DON on organ weights of chickens is summarized in Table 3.
Regarding DON toxicity, this biomarker is highly variable and results are contradictory.
The weight of organs expressed as a percentage of the body weight of the bird is named
relative weight (RW). Some organs seemed to be the most affected in different studies
as, for example, organs with high turnover of protein such as liver, immune organs and
small intestine [14]. The RW of liver decreased in birds fed 18 mg DON/kg feed during 5
weeks [68], but this parameter remained unaltered using the same dose of toxin during
12 weeks, and this may be explained by the difference in the duration of exposure [70].
Indeed, the time of toxin exposure may be a significant factor as the organ initially swells
with toxin exposure followed by shrinkage [53]. Similarly, in broiler chickens exposed to
DON at different levels (up to 10 mg/kg), a significant decrease of liver RW is observed
at week 3 of the trial [55]. However, in another trial, this parameter increased temporally
in the second week of exposure for broilers fed a low DON diet (1.68 mg DON/kg) [61].
The changes observed on the RW of the liver might be associated to lipid metabolism
alterations [63].
It has been previously observed that 10 mg of DON/kg diet for 35 days decreased the
RW of kidneys of broiler chickens and it has been suggested that DON alter the indicated
organ cells [76]. In contrast, other reports indicated that the RW of kidneys remained
unaltered [62,65,68,70].
The RW of gizzard increased in several studies after DON exposure of broiler chick-
ens [19,64,65,68,70,76]. The increase of RW of gizzard might be directly related to a
difference in the density of the diets or might be a result of the irritation of the upper
gastrointestinal tract [68].
The RW of small intestine of broilers fed 5 mg/kg DON for 21 days decreased [49].
In the same manner, Yunus et al. [77] reported a reduction in the RW of duodenum and
jejunum, and they suggested that this decrease could be due to the reduction of villus
height which then resulted in decreased digestion of nutrients and energy.
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Table 3. Effects of deoxynivalenol (DON) on relative organ of weights of chickens.
DON 1 (mg/kg) Diet Exposure Duration (d) Reported Effects 2 Reference
Up to 1.87 28 No effect on crop, proventriculus, gizzard, intestines, heart, liver,pancreas, kidneys, testes, adrenals, and thyroids [45]
1 or 5 35 No effect on RW of heart, proventriculus, gizzard, pancreas, liver, smallintestine, cecum, colon, thymus, spleen and bursa of Fabricius [33]
5 21 ↓ RW of small intestine, = RW of heart, gizzard, pancreas, caecum,colon, and spleen [49]
5.9 or 9.5 56 No effect on RW of liver, kidney, spleen, and bursa of Fabricius [53]
2, 5 or 10 112 ↑ RW of spleen (at 5 mg/kg) [54]
2.5, 5 or 10 35 ↓ RW of liver [55]
10 35 No effect on RW of bursa of Fabricius, spleen, and thymus [27]
10 35 ↑ RW of gizzard, ↓ RW of kidneys, = RW of brain, heart, pancreas, liver,lung, thymus, spleen, and bursa of Fabricius [76]
1.68 or 12.20 35 ↑ RW of liver and spleen, = RW of heart and thymus [61]
1.68 or 12.20 35 ↓ RW of duodenum and jejunum, = RW of proventriculus and gizzard [77]
Up to 14 35 ↑ RW of heart, ↓ RW of spleen, = RW of proventriculus, gizzard, liver,kidneys, small intestine, and bursa of Fabricius [62]
5 or 15 42
↑ RW of gizzard and thymus, ↓ RW of colon and small intestine, = RW
of heart, proventriculus, pancreas, liver, kidneys, cecum, spleen and
bursa of Fabricius
[19]
15 21 ↑ RW of gizzard, heart and bursa of Fabricius, = RW of proventriuclus,liver and kidney [63]
16 21 ↑ RW of gizzard, = RW of proventriculus, spleen, liver, and kidney [64]
16 21 ↑ RW of gizzard, = RW of proventriuclus, liver, kidneys, spleen, andbursa of Fabricius [65]
16 21 ↑ RW of gizzard and bursa of Fabricius, = RW of proventriculus,pancreas, liver, kidneys, and spleen [66]
16 21 No effect on RW of liver, left kidney, heart, spleen, pancreas,proventriculus, gizzard, and bursa of Fabricius [67]
9 or 18 35 ↓ RW of liver, = RW kidney, heart, proventriculus, testes, spleen, bursaof Fabricius, and ↑ RW of gizzard [68]
18 84 ↑ RW of gizzard, = RW liver, kidney, heart, proventriculus, spleen,bursa of Fabricius, and testes [70]
1 DON, deoxynivalenol; 2 RW, relative weight; ↑, increase; ↓, decrease; =, unaffected.
Regarding the immune organs, different results have been reported using the same
DON concentration during the same exposure time; the RW of bursa of Fabricius of birds
did not change after feeding 16 mg DON/kg of feed for 21 days [65] and, using the same
trial conditions, an increase of the RW of bursa of Fabricius was found [66]. Results of
these studies are highly variable, suggesting that organ weights might not be a good
indicator of DON toxicity [78]. An increase of the RW of spleen for broilers fed a low
level of DON (1.68 mg/kg) at week 4 was reported [61]. Similarly, the RW of spleen was
higher in the chickens fed 5 mg/kg of DON contaminated diet and this increase was
interpreted as a consequence of the irritation of chicken’s immune system by the toxin,
the swelling of this organ and some alterations on a cellular level [54]. Nevertheless,
the indicated immune organ was reduced in Lohman chickens fed up 14 mg DON /kg
for 5 weeks [62]. In other studies, the RW of spleen was not affected by DON chickens’
diets [19,33,49,53,60,65,68,70,76]. In our recent study, a significant increase of thymus of
birds exposed to DON at 5 or 15 mg/kg for 42 days was reported [19].
Due to the contradiction between results, it can be considered that RW of organs
might not be a very precise biomarker of DON toxicity in birds. However, based on the
frequencies of effects of DON on RW of organs, the RW of gizzard being the one the most
impacted by DON, it can be considered as a promising biomarker.
Toxins 2021, 13, 217 12 of 27
3.3. Intestinal Morphology
As all trichothecenes, DON is a small molecule that has the capacity to passively cross
through cell membranes and to be easily absorbed by the epithelium cells of the intestine.
These epithelium cells can be exposed to high concentrations of DON following ingestion
of contaminated diets [21]. On the other hand, the intestinal tract is a very important
barrier to ingested feed contaminants and is also the first line of defense against various gut
antigens [79]. Moreover, it has been reported that DON alter intestinal morphology [33].
The studies reporting the impairment of intestinal morphology parameters in chickens are
listed in Table 4.
Table 4. Effects of deoxynivalenol (DON) on morphological parameters of small intestine of chickens.
DON 1 (mg/kg) Diet Exposure Duration (Days) Reported Effects Reference
1 or 5 35 ↓ villus height of jejunum↓ villus surface area [33]
2.88 to 4.38 23 ↓ villus height of duodenum [80]
5 21 ↓ height and width of villi in duodenum [49]
5 28 ↓ villus height and villus height to crypt depth ratio in the duodenum [50]
7.54 21 ↓ villus height and crypt depth in the duodenum and jejunum [81]
6.62 to 7.90 21 ↓ density of small intestine, ↓ villus height in the jejunum, ↓ villus height,and crypt depth in the ileum [51]
2, 5, or 10 112 = villus height of jejunum and ileum [54]
10 21 ↓ villus height, ↑ crypt depth, ↓ villus height to crypt depth ratio inthe duodenum [82]
10 35 = length and density of different segments of gastrointestinal tract [58]
10 42 ↓ villus height of jejunum, = crypt depth and villus height and crypt depth [83]
10 42 ↓ villus height in the duodenum and jejunum [60]
1.68 or 12.20 35 ↓ villus height, ↑ lengthof duodenum and jejunum [77]
5 or 15 42 ↑ length and ↓ density of small intestine, = villus height and crypt depth [19]
Up to 18 21 ↑ villus height in the mid-ileumNo effects on crypt depth and goblet cells per villi counts [69]
1 DON, deoxynivalenol; ↑, increase; ↓, decrease; =, unaffected.
The density of the intestine was identified as the ratio between the absolute weight of
small intestine and its length. Birds fed DON-contaminated diets from 1 to 21 days had
lower intestinal density [51]. In broilers exposed to 1.68 or 12.20 mg/kg for 35 days, DON
exposure has shown to produce a reduction of the weights of duodenum and jejunum
and an increase of length of both segments and, consequently, DON decreased the small
intestine density, in a dose- and time-dependent manner [77]. Additionally, the length
was lower, and the density of the small intestine was higher in broilers receiving 5 and
15 mg DON/kg compared with controls [19]. Contaminated DON feed at concentration
3–4 mg/kg, which is below the European maximum guidance level, resulted in a decreased
duodenal villus height [80]. Jejunal and ileum histological analysis revealed that broiler
chickens exposed to the DON diets for 34 days had shorter villi and reduced crypt depth
than control birds [51]. Additionally, it has been shown that chickens consuming DON (5
or 10 mg/kg feed) had shorter and thinner villi compared to chickens ingesting control
diets [49,60,82,83]. It has been also reported a significant reduction of villus height, villus
surface area and muscularis thickness in jejunum of broiler chickens upon feeding naturally
contaminated diets with DON (1 or 5 mg/kg feed) [33]. Data reported by Yunus et al. [77]
indicated that feeding 12.20 mg/kg of DON contaminated diet to broiler chickens resulted
in a reduced villus height in the duodenum and jejunum. Similarly, feeding DON contami-
nated feed (7.54 mg/kg) for 21 days decreased the villus height and crypt depth both in
duodenum and jejunum of broiler chickens [81]. In the same manner, villus height and
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villus height to crypt depth ratio in the duodenum were decreased in chickens receiving
the guidance value for 4 weeks [50]. Only one study shows opposite results regarding the
intestine morphology, as they observed that feeding diets at a concentration up to 18 mg of
DON/kg of feed linearly increased broiler villi heights [69]. In recent reports villus height
was unaffected by the dietary inclusion of DON [19,54].
Decrease of villus height may be due to villus contraction and leads to the impairment
of nutrient transport and utilization, resulting in alteration of gain weight of animals fed
DON [84]. Furthermore, Robert et al. [85] indicated that the shortening of villus height
produced by DON may be explained by the implication of this mycotoxin in the balance
between epithelial cell proliferation and apoptosis. As such, the adverse effect of DON
on the villus height can be linked with an impaired nutrient digestion due to a reduced
number of differentiated epithelial cells [86].
After a mechanical or toxic damage, more enterocytes need to be generated to migrate
progressively along the villus toward the tip which induced the change in crypt depth [87].
In addition, change in crypt depth in birds fed DON could be attributed to the capacity of
DON to reduce cell proliferation [81]. The crypt-depth to villus-height ratio was calculated
to assess the intestinal architectural changes after the treatment [87].
Changes observed in morphology and histology of small intestine could be due to
the irritant effects of DON on the upper gastrointestinal tract and the inhibition of protein
biosynthesis, leading to the alteration of the absorption and digestion mechanisms which
negatively affect bird growth [79,81].
To conclude, we could consider that the decrease of villus height is the most frequent
effect reported among studies. This biomarker could be useful in the research on developing
and efficacy proving of mycotoxin-detoxifying agents. Moreover, research is now growing
in the field of gut health and focusing on the effects of mycotoxins in the gastro-intestinal
tract (GIT).
3.4. Biochemical and Hematological Parameters
Biochemical and hematological parameters are used to infer the health status of
animals. The most significant results of the effect of DON on biochemical blood parameters
are indicated in Table 5.
Table 5. Effects of deoxynivalenol (DON) on blood biochemistry and hematology of chickens.
DON 1 (mg/kg) Diet Exposure Duration (Days) Reported Effects 2 Reference
2.95 28 ↓ levels of Tot Prot, Alb ↑ALT, AST and ALP. [88]
3 42 ↓ levels of Tot Prot, mg, Trig and free glycerol, ↑ ALT activity [89]
3 42 ↓ Tot Prot, Trig and free glycerol, ↑ ALT activity [90]
4.7 or 8.2 56 Quadratic responses in serum concentrations of Alb and γ-GT, ↓ lipaseactivity, ↑ UA, hemoglobinemia and erythrocytosis [52]
10 35 ↓ of plasma Tot Prot and UA, ↓ plasma Trig level (tendency), [27]
10 35 ↓ level of ALT, ↑ serum Chol and Trig [58]
Up to 14 35 = Glu, Tot Prot, Hct and Hgb [62]
5 or 15 42 ↓ CK (at 5 mg/kg) and ↓ level of Chol (at 15 mg/kg) [19]
5 or 15 42 ↓ Hgb (dose-dependent), ↓ erythrocytes (at 15 mg/kg) [91]
15 21 ↑ activities of AST, LDH and γ-GT. [63]
16 21 ↓ Trig, alterations in blood erythrocyte count, Hgb and Hct [64]
16 21 ↓ Glu level [65]
16 21 No effect on Glu, ALT, AST, Creat and Hgb [67]
9 or 18 35 ↓ Glu, Trig and LDH, ↑ Creat,↓ in Hgb and Hct [68]
18 63 ↓ Hgb concentration, erythrocyte count and Hct [92]
18 84 ↓ in Hgb concentration at 28 days [70]
50 21 No effect on hematological parameters [92]
1 DON, deoxynivalenol; 2 Tot Prot, total protein; Alb, albumin; UA, uric acid; Chol, cholesterol; Trig, triglycerides; ALT, alanine transaminase;
AST, aspartate transaminase; ALP, alkaline phosphatase; γ-GT, gamma-glutamyl transferase; LDH, lactate dehydrogenase; Glu, glucose;
Creat, creatinine; CK, creatine kinase; Hgb, hemoglobin; Hct, hematocrit; MCHC, mean corpuscular hemoglobin concentration; ↑, increase;
↓, decrease; =, unaffected.
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Dietary DON may affect the enzymes reflecting liver and kidney activities such as
lactate dehydrogenase (LDH), alanine aminotransferase or transaminase (ALT), aspartate
transaminase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (γ-GT),
creatine kinase (CK), and creatinine. Broilers exposed to 15 mg DON/kg feed during
21 days had higher AST activity in blood [63]. However, the same dietary level in chickens
feeding during 42 days did not affect this enzymatic activity [19]. ALP and AST activities
increased in broilers exposed to 2.95 mg DON/kg feed for the second last week of the
trial [88]. Faixová et al. [89,90] showed an elevation of serum ALT activity in broilers
exposed to 3 mg DON/kg feed for 6 weeks. However, broilers fed DON (10 mg/kg) for
35 days had lower ALT [58]. Swamy et al. [52] reported that DON at 4.6 mg/kg increased
the levels of γ-GT activity. These results were in accordance with a previous report of
chickens fed 15 mg DON/kg [63]. Contaminated diet with DON at 5 mg/kg decreased the
serum creatine kinase level in broiler chickens aged 42 days [19], reflecting the reduction
of this enzyme from the circulation [93]. Generally, the changes obtained in enzymatic
activities might be due to hepatic disorders, chronic liver damage, leakage of the enzymes
into the blood, biliary obstruction, or kidney affliction [52,58,88].
For biochemical parameters reflecting lipid metabolism, higher cholesterol level and
triglycerides were observed in broilers fed DON at 10 mg/kg for 35 days [58]. The increased
cholesterol level may suggest liver or kidney damage function and a high stress status
of the bird [58]. The increased level of triglycerides might be related to lipid metabolism
alteration and or to biliary obstruction [58]. These results are in contrast with the pre-
vious and actual findings which observed decreased cholesterol and triglycerides lev-
els in broilers [19,27,64,68,89,90]. This is in agreement with the meta-analysis report of
Andretta et al. [94] indicating that broilers fed challenged mycotoxins (T2, FBs, DON, OTA,
and ZEN) had lower total cholesterol (−14 %) and lower triglycerides (−39 %) compared
to negative control birds. It was suggested that these changes in indicated biochemical
parameters could be explained by involvement of liver and a shift of concentrations from
the blood to the liver [95].
Regarding biochemical parameters reflecting protein metabolism, it has been described
that the total plasma protein and albumin levels of chickens fed a contaminated diet with
2.95 mg DON/kg feed during 2 weeks of exposure were decreased compared to control [88].
The reduction of total protein level after feeding DON to broilers was observed also in
previous reports [27,89,90]. This decrease could be the result of protein and DNA synthesis
inhibition induced by DON [14]. Additionally, the decreased plasma protein level may be
related to the decrease of feed intake. DON toxicity is expressed also through a change in
the profile of uric acid (UA) [27,52]. The decreased level of UA may be attributed to the
efficiency of amino acid utilization, changes in enzyme systems, altered renal filtration,
and reabsorption rates [95].
Blood hematological parameters serve as indicators of the physiological state of
birds [96], but very limited information is available regarding the effect of DON exposure
on hematological variables in poultry. The absence of significant effect of DON exposure on
hematology of broiler chickens exposed to different DON concentrations (up to 16 mg/kg
feed) at 21 or 35 days has been shown [62,67]. Even 50 mg/kg of DON did not change these
indicators in broiler chickens aged 21 days [92]. In other studies, a significant decrease in
hemoglobin concentration was observed accompanied or not with a decrease on hematocrit
and a decrease on erythrocytes count of birds exposed to DON mycotoxin [52,64,65,70,91,
92]. In their meta-analysis, Andretta et al. [94] reported that the presence of mycotoxins
in broiler diets decreased the hematocrit and the hemoglobin concentration by 5 % and
15 %, respectively. The decreasing of hematocrit hypothesized that hematopoietic tissue
may be affected by DON toxin [97]. However, no hemorrhage or hemolysis was observed
in broilers. The decrease of hemoglobin and erythrocytes does not necessarily mean that
DON induces anemia in poultry, because values are within the range of reference [96].
Moreover, the decrease of hemoglobin and erythrocytes is a marker of immune system
alteration.
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The most frequent effect of DON in blood biochemistry and hematology of chick-
ens among studies was the decrease of blood protein, triglycerides, hemoglobin, and
erythrocytes and the increase of ALT. These indicators could be useful to evaluate the
DON effect on the physiological and hemostatic state of chickens. However, it should
be noted that blood biochemical and hematological parameters were slightly affected by
DON contaminated feed, as these parameters were still within their physiological reference
range [98–100], and therefore, of limited physiological relevance.
3.5. Biomarkers Related to Immune System
Few studies have been conducted regarding DON effects on poultry immune system,
despite that the first outcome of DON toxicity is immune system functions and responses.
As the immune system has rapidly proliferating cells and tissues with high rates of pro-
tein turnover, it is consequently considered the most susceptible system to DON and
trichothecenes mycotoxicosis [14]. Responses to common vaccines as Newcastle disease
virus (NDV) and infectious bronquitis virus (IBV) are considered as humoral immune
response parameters [27,62]. Leukocytes apoptosis and lymphocytes proliferation are
considered as cellular immune responses to DON detrimental effects [27,101]. Furthermore,
the production of proinflammatory cytokines could be used as an indicator to evaluate
the effects of DON contaminated diets exposure on immune system competence or modu-
lation [102]. The effect of DON on immune system functions and responses through the
evaluation of those indicators mentioned above are reviewed in Table 6.
Table 6. Effects of deoxynivalenol (DON) on immune biomarkers of chickens.
DON 1 (mg/kg) Diet Exposure Duration (Days) Reported Effects 2 Reference
1.6 34 ↓ IL-6, = IFN- γ, IL-1β, IL-17, and IL-10 in cecal tonsils [103]
2 42 ↓ NDV titers at 28 days and 42 days, ↑mRNA expression of IL-lß and IL-6,↓mRNA expression of IFN-γ in spleen [104]
Up to 3.8 70 ↑ IFN- γ gene expression in cecal tonsils [105]
Up to 5 35 ↑mRNA expression of IL-6 in the duodenum, ↓mRNA expression of IL-8and IL-10 in the jejunum (quadratic trend) [102]
5 28 No effect on LITAF and IL-1β in spleen and bursa of Fabricius tissues [50]
4.7 or 8.2 56 = IBV [52]
5.9 or 9.5 56 ↓ B cells and T cells [53]
2, 5 or 10 112 Apoptosis in chicken spleen lymphocytes [54]
10 35 ↓ of lymphocytes and ↓ IBV [27]
10 35 In plasma: ↓ LITAF, = IL-8, in jejunum: ↓ IL-1β, IFN-γ, TGFBR1, = LITAF,IL-8 and NF-kB1 [106]
10 35 ↓ IBV titers [58]
12.2 35 ↑ NDV (14 days/28 days), ↓ IBV (35 days) [61]
3.5 to 14 35 ↓ NDV titers [62]
5 or 15 42 = NDV and IBV, ↑ plasma IL-8, ↑ the mRNA of IL-6, IFN- γ and IL-1β injejunum tissues (at 5 mg/kg) [91]
18 63 No effect on NDV [92]
18 126 ↓ NDV [92]
1 DON, deoxynivalenol; 2 NDV, Newcastle disease virus; IBV, infectious bronquitis virus; IFN-γ, interferon gamma; IL-1β, interleukin 1-β;
IL-6, interleukin 6; LITAF, lipopolysaccharide-induced TNF-α factor, TGFBR1, transforming growth factor beta receptor I; NF- kβ, nuclear
factor kappa β; CCK-8, cell counting kit-8; IL-10, interleukin 10, IL-17, interleukin 17; ↑, increase; ↓, decrease; =, unaffected.
3.5.1. Biomarkers Related to Humoral Immune Response
Dänicke et al. [62] suggested that the antibody titers against NDV could be a relevant
biomarker for DON effects on protein synthesis inhibition due to the reduction of antibody
titers to NDV when broiler chickens fed up 14 mg of DON/kg feed for 5 weeks. In the same
manner, broilers exposed to a mixture of Fusarium mycotoxins, included DON, presented a
decreased NDV titers at 28 and 42 days of age [104]. Additionally, NDV antibody titers
decreased in White Leghorn chicks fed 18 mg of DON/kg of feed at 18 weeks [92]. However,
the exposure to 12.2 mg of DON/kg of feed of broilers for 5 weeks increased titers against
NDV at week 2 and week 4 but decreased numerically at week 5 [61]. As trichothecenes,
DON is both immunostimulatory and immunosuppressive, depending on the level and
the length of exposure [101]. The enhancement or the depression of the response to NDV
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observed may be due to the ability of DON to modulate the immune response during
chronic exposure. Concerning the antibody titers against IBV, it was concluded that it
is also a good indicator of depression of protein synthesis induced by the exposure of
DON [27]. Antibody titers to IBV decreased in broiler chickens receiving DON at 10, 12.2,
or 12.6 mg/kg for 5 weeks [27,61]. Meanwhile, no effect on the IBV titers was found
following exposure of broiler chickens to different concentrations of DON (4.7, 8.2, or
9.7 mg/kg of feed) for 21 and 42 days [52]. Furthermore, no effects of a concentration of
12.2 mg DON/kg were found on antibody against IBV titers in broiler chickens after 14
and 28 days [61].
The discrepancies in results of these biomarkers of effect might indicate that the
humoral immune response of broilers fed DON is variable, and further studies should
be undertaken [61]. It might be interesting for these studies to take into account parent
breeder vaccination schedule and chick maternal antibody levels.
3.5.2. Biomarkers Related to Cellular Immune Response
The first molecular target of DON and other trichothecenes is the ribosome. DON
inhibits protein synthesis via binding to the peptidyl transferase region of the 60S subunit of
the ribosome and interfering with the elongation step [107]. Ribosome binding leads first to
the activation of ribosomal-associated protein kinase R (PKR) and tyrosine protein kinase
(Hck) and, subsequently, the activation of mitogen activated protein kinases (MAPKs)
signaling, including p38, Jun N-terminal kinase (JNK) and extracellular signal-regulated
kinase 1 and 2 (ERK1/2) [108]. The mechanism regulating this activation is named the
“ribotoxic stress response” [107]. The activation of MAPKs pathway by DON in vivo and
in vitro suggests that the ribotoxic stress response mediates DON toxicity [109]. MAPKs
are involved in cell growth, differentiation and apoptosis [108]. Additionally, it might
include leukocyte apoptosis and lymphotoxicity [110].
Leukocytes are target to DON and trichothecenes mycotoxicosis [110]. As described
previously, DON is both immunostimulatory and immunosuppressive and it has been
reported that at high doses, DON is immunosuppressive and causes leukocyte apop-
tosis [111]. The apoptosis was induced by the activation of c-Jun terminal kinase, p38
mitogen-activated protein kinase and caspases. At high doses, trichothecenes produced
injuries in spleen, thymus, bone marrow, and intestinal mucosa, leading to immunosup-
pression, and potentially increased susceptibility to several pathogens [112]. Exposure
to high DON concentrations induces macrophages apoptosis which can lead to innate
immune function suppression [101]. Moreover, the acute oral exposure to trichothecene
mycotoxins produced adverse effects to actively dividing cells in bone marrow, lymph
nodes, spleen, thymus, and intestinal mucosa [110].
Trichothecenes have both effects of enhancement or impairment of mitogen-induced
lymphocyte proliferation, depending on the dose of exposure, what has been demonstrated
in in vitro and ex-vivo studies [111]. In vitro DON exposure induced apoptosis in murine
T cells, B cells, and IgA+ cells isolated from spleen, Peyer’s patches, and thymus [113].
This induction of apoptosis was dependent on lymphocyte subset, tissue source, and
glucocorticoid induction [110]. In vitro lymphotoxicity of type B and type A trichothecenes
depends on the degree of acylation in substituent groups, according to Pestka et al. [111].
Furthermore, Sharma [114] noted that lymphocytes cytotoxicity is a result of a DON
immunotoxic effect. DON has the ability to promote in vitro apoptosis in chicken spleen
lymphocytes and tissue [54,115]. Ingestion of DON from 5.9 to 9.5 mg/kg feed reduced
the B cells and T cells counts in broiler chickens [53]. In the in vivo study conducted by
Ghareeb et al. [27] blood lymphocytes count was decreased in broilers receiving DON
(10 mg/kg feed) for 35 days.
The observed changes on leukocytes and lymphocytes in mycotoxicosis conditions
can be attributed to the immune system being sensitive to DON [10].
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3.5.3. Production of Proinflammatory Cytokines
After MAPKs activation, p38 and ERK induced gene transcription and enhanced
mRNA stability [107]. The induction of genes expression included also the induction of
transcription and post transcriptional factors, such as nuclear factor kβ (NF-kβ) and leads
to promote proinflammatory genes [107,108]. Proinflammatory cytokines might serve as
relevant biomarkers of effect that are predictive of DON’s negative effects in target animals.
The gene expression of interferon gamma (IFN-γ) in the cecal tonsils of chickens fed
Fusarium mycotoxins challenged with coccidian was upregulated [105]. Broiler chickens
exposed to a mixture of mycotoxins, in which DON concentration was approximately
2 mg/kg, for 42 days had higher expression of interleukin 1-β (IL1-β) and IL-6 and lower
expression of IFN-γ in spleen tissues [104]. In a recent study conducted by Lucke et al. [102],
the gene expression of IL-6 was increased in broilers receiving up 5 mg/kg for 35 days.
Similarly, DON at 5 mg/kg feed upregulated the relative gene expression of IL-6, IL1-β
and IFN-γ in broiler chickens at 42 days.
The upregulation of cytokine gene expression by DON was explained by the abil-
ity of this mycotoxin to inhibit synthesis of labile protein repressors of mRNA expres-
sion [105,116]. Zhou et al. confirmed that the induction of gene expression of cytokines is a
result of DON-induced transient expression of specific mRNAs responsible for impairment
of synthesis of high turnover proteins [117]. It has been suggested also that this induction
of immune related genes by DON mycotoxin is associated to a higher transcription factor’s
binding activity in leukocytes at the transcription level and to a higher mRNA stability
at the post-transcription level [101,105]. In addition to that, the upregulation of cytokines
production is linked to the transcription factor NF-κB activation [108].
However, in response to DON (10 mg/kg feed), broiler chickens had lower LITAF in
plasma and lower IL-1β, IFN- γ and TGFBR1 in jejunum, and no effect was observed on
plasma IL-8 and LITAF nor on IL-8 and NF-kB1 in the jejunum [106]. Grenier et al. [103]
reported a downregulation of IL-6 in cecal tonsils in broiler fed 1.6 mg DON/kg feed.
No effect on LITAF and IL-1β in spleen and bursa of Fabricius tissues was observed in
broilers exposed to 5 mg/kg DON for 28 days [50]. The differences obtained among
studies regarding the DON effect on cytokines production depends on the biological
matrix. For example, the determination of cytokines in serum could be a nonsuitable
indicator to evaluate the cytokine production due to their short-half-life or due to the low
sensitivity of the method used [117]. Another explanation could be the modulating effect
of DON on the innate immune response [106]. The ability of DON to upregulate cytokines
release is associated to the effect of DON on the innate immune response, leading to the
impairment of chicken’s resistance to infectious disease [106]. Furthermore, DON-induced
proinflammatory cytokines can be useful in the underlying cause of DON-induced feed
refusal. Infection induced anorexia could be explained by the upregulation of relative gene
expression of IL-1β andIL-6 [118].
3.6. Biomarkers Related to Welfare Parameters
To evaluate welfare related parameters induced by DON toxicity in chickens, the
indicators linked with oxidative stress and to physiological, hormonal, and behavioral
welfare are highlighted in Table 7.
3.6.1. Response to Oxidative Stress as Welfare Biomarker
DON induces oxidative stress, which is defined as the imbalance between the reactive
oxygen species (ROS) and the antioxidant defenses [125]. DON exposure to chicken’s expo-
sure to DON induced the overproduction of free radicals, such as the upregulation of the hy-
poxia inducible factor 1, subunit alpha (HIF-1α) and heme-oxygenase (HMOX) in jejunum
and xanthine oxidoreductase in the liver of broiler chickens exposed to 7.54 mg DON/kg
contaminated feed for 21 days [81]. An increased production of ROS leads to DNA damage,
protein oxidation and lipid peroxidation [126]. The exposure of broiler chickens exposed to
DON (10 mg/kg feed) resulted in DNA damage in spleen leukocytes or in blood lympho-
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cytes [76,121,122]. Regarding the parameters associated with lipid peroxidation, it has been
reported that DON increased thiobarbituric acid reactive substances (TBARS) in jejunum
and malondialdehyde (MDA) in liver, kidney, serum, and jejunum [76,83,120,123]. On the
other hand, the oxidative stress is characterized by a reduction in cellular antioxidant levels
with a decreased activity of antioxidant enzymes such as superoxidase dismutase (SOD),
catalase (CAT) and glutathione-related systems (GSH), including glutathione peroxidase
(GPx) [126]. In vivo and in vitro studies reported lower levels of SOD in serum [83], GSH in
the liver of broilers [120], and both parameters in chicken embryo fibroblast DF-1 cells after
DON exposure [119]. The ingestion of DON reduced the GSH in liver, jejunum and ileum,
the 2,2’-azino-bis (3- ethylbenzothiazoline-6-sulphonic acid) (ABTS) in the jejunum, and
the ferric reducing ability (FRAP) in liver of broilers chickens [123]. Oxidative stress data
may constitute an effective source of information to know the bird’s welfare assessment.
Table 7. Effects of deoxynivalenol (DON) on welfare related parameters in chickens.
DON 1 (mg/kg) Diet Exposure Duration (Days) Reported Effects 2 Reference
Response to oxidative stress as welfare biomarker
100–2000 ng/mL 24 h ↑ ROS and MDA, ↓ GSH and SOD in embryo fibroblast DF-1 cells [119]
7.54 21 ↑ HIF-1α and HMOX in jejunum↑ xanthine oxidoreductase in liver [81]
3.4 or 8.2 14 ↑MDA in liver, kidney and serum, ↓ GPx activity in liver tissue [120]
10 35 ↑ TBARS in jejunumDNA damage in blood lymphocytes [76]
10 42 ↓ SOD activity in serum and ↑MDA or TBARS in the jejunal mucosa [83]
10 17 ↑ DNA fragmentation in spleen leukocytesNo effect on plasma and liver MDA [121]
10 35 ↑ blood lymphocyte DNA damageNo effect on TBARS [122]
19.3 14
↑ TBARS in jejunum
No effects on superoxide anion levels of jejunum and ileum
↓ GSH and ABTS in jejunum
[123]
Biomarkers related to physiological, hormonal, and behavioral welfare
Up to 14 35 No significant effect on H/L ratio [62]
4.6 15 ↑ plasma corticosterone [46]
5.9 or 9.5 56 Alterations on brain neurochemistry ↑5-hydroxytryptamineand serotonin [124]
10 35 ↑ H/L ratio [27]
10 35 ↑ plasma corticosterone, H/L ratio, and duration of tonicimmobility reaction. [57]
5 or 15 42
↓ plasma corticosterone
No effect on H/L ratio
↑ duration of tonic immobility reaction
[91]
Up to 18 21 ↑ H/L ratio [69]
1 DON, deoxynivalenol; 2 MDA, malondialdehyde; GPx, glutathione peroxidase; TBARS, thiobarbituric acid reactive substances, HIF-1α,
hypoxia inducible factor 1, subunit alpha; HMOX, heme-oxygenase; ROS, reactive oxygen species; GSH, glutathione-related systems; SOD,
superoxidase dismutase; ABTS, 2, 2’-azino-bis (3- ethylbenzothiazoline-6-sulphonic acid); H/L, heterophil to lymphocyte ratio; ↑, increase;
↓, decrease.
3.6.2. Biomarkers Related to Physiological, Hormonal, and Behavioral Welfare
Only a few studies have been carried out on the impact of DON contamination of
poultry feed on biomarkers related to physiological, hormonal, and behavioral welfare.
Onbasilar and Aksoy [127] reported that the impairment of the number of circulating leuko-
cytes, such as heterophils and lymphocytes, is part of the physiological stress. Therefore,
the heterophil to lymphocyte ratio (H/L) was used as a good indicator to evaluate the
stress in poultry [128].
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The stress index was elevated in broilers fed DON (10 or 18 mg/kg) for 21 or
35 days [27,57,69]. However, Dänicke et al. [62] did not report significant differences
on H/L ratio in broilers fed a contaminated diet with a concentration of 14 mg/kg of DON
per kg. Likewise, the H/L ratio was higher in broilers fed 5 or 15 mg of DON/kg of feed,
but this elevation was not statistically significant [91].
The elevation of circulating levels of corticosterone is included also within the physi-
ological stress biomarkers [127]. Antonissen et al. [46] showed that broilers exposed to a
DON (4.6 mg/kg) contaminated diet for 15 days had higher mean plasma corticosterone
levels than chickens fed control diet. Similarly, Ghareeb et al. [57] observed that feeding
broilers with 10 mg/kg of DON for 35 days, increased the plasma corticosterone level.
The elevation of corticosterone was related with the upregulation of gene expression of
IL-1β and IL-6 proinflammatory cytokines [129]. The increase in corticosterone might be
associated with the mycotoxin induced increase in susceptibility to infectious diseases [80].
The fear response is a welfare-related behavior evaluated by tonic immobility reaction
and can provide more information on chicken’s stress status [57,130]. The duration of
tonic immobility was longer in broilers exposed to 10 or 15 mg DON/kg [57,91]. This
effect could be related to the adverse effect of DON on brain regional neurochemistry.
Indeed, the inclusion of contaminated grains with Fusarium mycotoxin in the diet of broiler
chickens for long-term (1–56 days) increased the concentration of 5-hydroxytryptamine
(5 HT) in the pons and in the cortex, which is responsible for the regulation of fear [124].
DON-induced stress altered brain neurochemistry of broilers by increasing serotonin levels
(strong satiety neurochemical), suggesting that DON caused partial feed refusal and growth
suppression [124]. Consequently, these adverse effects on bird’s welfare might be associated
with the mycotoxin induced increase in sensitivity to infectious diseases.
In summary, the frequencies of effects of biomarkers mentioned in this review are
recapitulated in Table 8.
It should be noted that the most frequent effect on these biomarkers appeared at
42 days (Table 8), indicating that sampling time and measurements of biomarkers at
42 days could be suitable to evaluate toxic DON effect on broilers, due to the fact that older
birds consume more total mycotoxins, which is estimated by feed intake (kg) x dietary
mycotoxin levels (mg/kg) [51]. Moreover, the differences in absorption, distribution,
metabolism and excretion processes could be age related and then could influence animal’s
response to mycotoxins [126].
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Table 8. Frequencies of effects of the nonspecific biomarkers of toxicity of deoxynivalenol (DON) in chickens at starter and grower cycles of growth.
Biomarkers Frequently Determined 1
No Effect ↑, Increase ↓, Decrease
Starter (at 21 Days) Grower (from 21 Days) Starter (at 21 Days) Grower (from 21 Days) Starter (at 21 Days) Grower (from 21 Days)
Productive parameters [46,48,67,71] [45,50,57–60] [68] [31,47,52,54,68,70] [33,49,61,63–66,69] [19,27,51,53,55,56,62]
RW of organs
Liver [63–67] [19,33,45,53,62,70,76] [61] [55,68]
Kidneys [63–67] [19,45,53,62,68,70] [76]
Gizzard [49,67] [33,45,62,77] [63–66] [19,68,70,76]
Small intestine [33,45,62] [49] [19,77]
Bursa of Fabricius [65,67] [19,27,33,53,62,68,70,76] [63,66]
Spleen [49,64–66] [19,27,33,53,68,70,76] [54,61] [62]
Thymus [27,33,61,76] [19]
Heart [49,67] [19,33,45,61,68,70,76] [63] [62]
Intestinal morphology
Villus height [19,54] [69] [49,51,81,82] [33,50,60,77,80,83]
Crypt depth [69] [19,83] [82] [51,81]
Blood biochemistry
Total protein [62] [27,88–90]
Albumin [52,88]
ALT [67] [88–90] [58]
ALP [88]
AST [67] [63] [88]
Triglycerides [58] [64] [27,68,89,90]
Glucose [67] [62] [65] [68]
Blood hematology
Hematocrit [92] [62] [64] [68,92]
Hemoglobin [67,92] [62] [64] [52,68,70,91,92]
Erythrocytes [92] [64] [52,91,92]
Lymphocytes [27,53,54]
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Table 8. Cont.
Biomarkers Frequently Determined 1
No Effect ↑, Increase ↓, Decrease
Starter (at 21 Days) Grower (from 21 Days) Starter (at 21 Days) Grower (from 21 Days) Starter (at 21 Days) Grower (from 21 Days)
Response to common vaccines




IL-8 [106] [91] [102]
IL-1β [50,103] [91,104] [106]
IFN- γ [103] [91,105] [104,106]
Oxidative stress parameters
MDA [121] [120] [83]
TBARS [122] [123] [76,83]
Physiological stress parameters
Stress index (H/L ratio) [62,91] [27,57,69]
1 ALT, alanine transaminase; ALP, alkaline phosphatase; AST, aspartate transaminase; NDV, Newcastle disease virus; IBV, Infectious bronquitis virus; IL-6, interleukin 6; IL-8, interleukin 8; IFN-γ, interferon
gamma; IL-1β, interleukin 1-β; MDA, malondialdehyde; TBARS, thiobarbituric acid reactive substances; H/L, heterophil to lymphocyte ratio.
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4. Conclusions
To conclude, DON-3S is the specific and the most suitable biomarker of exposure of
DON in chicken. The metabolic pathway that causes its formation could be considered as a
detoxification pathway in those animals, which probably explains the low susceptibility to
DON mycotoxicosis compared to other species. However further studies are needed to
elucidate exactly the metabolism leading from DON to DON-3S in poultry.
Among the biomarkers of effect highlighted in this review, the most relevant ones are
productive parameters, relative weight of gizzard, villus height, blood protein, triglycerides,
alanine transaminase, hemoglobin, erythrocytes, lymphocytes, response to NDV and IBV,
and stress index (H/L ratio). Intestinal cytokines (IL-6, IL-8, IL-1β, and IFN-γ), and TBARS
as an oxidative stress parameter could be also relevant biomarkers of toxicity of DON
in chickens.
DON could alter the production and bird’s health status through multiple pathways.
The biochemical and hematological alteration suggests the malfunctioning of immune
system. Furthermore, the intestinal alteration leads to the alteration on the absorption and
digestion process. The induction of proinflammatory release, corticosterone secretion and
oxidative stress, are involved in feed refusal and increased the susceptibility to infectious
disease. Studies cited in the current review were under experimental conditions, however,
it would be necessary to increase the proportion of research undertaken in field conditions.
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127. Onbaşilar, E.E.; Aksoy, F.T. Stress parameters and immune response of layers under different cage floor and density conditions.
Livest. Prod. Sci. 2005, 95, 255–263. [CrossRef]
128. Gross, W.B.; Siegel, H.S. Evaluation of the heterophil/lymphocyte ratio as a measure of stress in chickens. Avian Dis. 1983, 27,
972–979. [CrossRef] [PubMed]
129. Islam, Z.; Pestka, J.J. Role of IL-1β in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte
apoptosis in mice. Toxicol. Sci. 2003, 74, 93–102. [CrossRef] [PubMed]
130. Campo, J.L.; Gil, M.G.; Dávila, S.G.; Muñoz, I. Influence of perches and footpad dermatitis on tonic immobility and heterophil to
lymphocyte ratio of chickens. Poult. Sci. 2005, 84, 1004–1009. [CrossRef]
